Item no. |
HY-N5034-10mM |
Manufacturer |
MedChem Express
|
CASRN |
1071-23-4 |
Amount |
10 mM/1 mL |
Quantity options |
100 mg
10 mM/1 mL
1 g
5 g
|
Category |
|
Type |
Inhibitors |
Specific against |
other |
Purity |
98.0 |
Formula |
C2H8NO4P |
Citations |
[1]Kinoshita Y, et al. Phosphorylethanolamine content of human brain tumors. Neurol Med Chir (Tokyo). 1994 Dec;34(12):803-6. [2]Hui SCN, et al. In vivo spectral editing of phosphorylethanolamine. Magn Reson Med. 2022 Jan;87(1):50-56. [3]Calzada E,et al. Phosphatidylethanolamine Metabolism in Health and Disease. Int Rev Cell Mol Biol. 2016;321:29-88. doi: 10.1016/bs.ircmb.2015.10.001. [4]van der Veen JN, et al. A role for phosphatidylcholine and phosphatidylethanolamine in hepatic insulin signaling. FASEB J. 2019 Apr;33(4):5045-5057. [5]Nesic I, et al. Alterations in phosphatidylethanolamine levels affect the generation of Aβ. Aging Cell. 2012 Feb;11(1):63-72. |
Smiles |
NCCOP(O)(O)=O |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
Monoaminoethyl phosphate, NSC 254167, O-Phosphoethanolamine |
Shipping condition |
Room temperature |
Available |
|
Manufacturer - Type |
Natural Products |
Manufacturer - Applications |
Metabolism-protein/nucleotide metabolism |
Manufacturer - Targets |
Endogenous Metabolite |
Shipping Temperature |
Room Temperature |
Storage Conditions |
-20°C, 3 years; 4°C, 2 years (Powder) |
Molecular Weight |
141.06 |
Product Description |
Phosphorylethanolamine (Monoaminoethyl phosphate) is a membrane phospholipid and an important precursor of Phosphatidylcholine (HY-B2233B). It is found in most animal tissues and various human extracranial tumors, playing a critical role in membrane integrity, cell division, mitochondrial respiratory function, and more. Studies have shown that changes in the abundance of Phosphorylethanolamine are associated with Alzheimer's disease and Parkinson's disease. Lowering the ratio of Phosphorylethanolamine to Phosphatidylcholine in the liver can improve insulin signaling. Phosphorylethanolamine holds promise for research in the fields of cancer, neurodegenerative disorders, and metabolic diseases[1][2][3][4][5]. |
Manufacturer - Research Area |
Cancer; Metabolic Disease; Neurological Disease |
Solubility |
H2O : 125 mg/mL (ultrasonic) |
Manufacturer - Pathway |
Metabolic Enzyme/Protease |
Isoform |
Human Endogenous Metabolite; Microbial Metabolite |
Clinical information |
No Development Reported |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.